Study on the perceptions and practices related to the possibility of HIV transmission among higher education students in Santo Domingo de los Tsáchilas
DOI:
https://doi.org/10.56294/sctconf20231124Keywords:
Risk Factors, Preventive Methods, PerceptionAbstract
The human immunodeficiency virus (HIV) poses significant medical, social, and economic challenges, necessitating coordinated actions for its control. It is primarily transmitted through specific bodily fluids and can lead to acquired immunodeficiency syndrome (AIDS), affecting the immune system and predisposing individuals to opportunistic infections and cancers.A descriptive cross-sectional analytical study was conducted with university students in Santo Domingo de los Tsachilas to explore their perception of HIV transmission risk. A questionnaire based on the instrument by Bayés, Pastels, and Tuldrá (1995-1996) was used, administered through stratified random sampling to obtain a representative sample. Students exhibited varied perceptions regarding HIV transmission risk factors, highlighting gaps in knowledge and inadequate preventive methods. This situation underscores the need for effective educational and preventive interventions to enhance awareness and reduce infection rates. It is necessary to promote greater awareness of the risks of HIV and improve health education among university students. Strategies should be adapted to address perceptions and attitudes towards HIV, thereby contributing to a more informed and empathetic society towards this globally significant disease
References
1. Lamotte Castillo JA. Infección por VIH/sida en el mundo actual. MEDISAN. 2014;18(7):993.Consultado 4/7/2024. http://scielo.sld.cu/pdf/san/v18n7/san15714.pdf.
2. National Instituites of Health. Prevención del VIH. Conceptos básicos sobre la prevención de la infección por el VIH. Diciembre 11, 2023. https://hivinfo.nih.gov/es/understanding-hiv/fact-sheets/conceptos-basicos-sobre-la-prevencion-de-la-infeccion-por-el-vih
3. Hsu K, Rakhmanina N. VIH en niños y adolescentes: American Academy of Pediatrics; 2024.[citado15 de febrero de 2024]. https://www.healthychildren.org/Spanish/health-issues/conditions/sexually-transmitted/Paginas/hiv-human-immunodeficiency-virus.aspx
4. Elsevier. Elsevier Connect. [citado 15 de agosto de 2023]. Inmunología celular y molecular. Disponible en: https://www.elsevier.com/es-es/connect/estudiantes-de-ciencias-de-la-salud/inmunologia-celular-y-molecular
5. Nasrallah GK, Al-Buainain R, Younes N, Dargham SR, Al-Sadeq DW, Elhassan M, et al. Screening and diagnostic testing protocols for HIV and Syphilis infections in health care setting in Qatar: Evaluation and recommendations. PloS One. 2023;18(2):e0278079. Disponible en: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0278079&type=printable DOI: https://doi.org/10.1371/journal.pone.0278079
6. Tumpach C, Rhodes A, Kim Y, Ong J, Liu H, Chibo D, et al. Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA. Viruses. 22 de julio de 2023;15(7):1606. Disponible en: https://doi.org/10.3390/v15071606 DOI: https://doi.org/10.3390/v15071606
7. Plemper RK. Measles Resurgence and Drug Development. Curr Opin Virol. 1 de abril de 2020;41:8-17.Disponible en: https://doi.org/10.1016/j.coviro.2020.02.007 DOI: https://doi.org/10.1016/j.coviro.2020.02.007
8. Waters L, Winston A, Reeves I, Boffito M, Churchill D, Cromarty B, et al. BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022. HIV Med. 2022;23(S5):3-115. Disponible en: https://doi.org/10.1111/hiv.13446 DOI: https://doi.org/10.1111/hiv.13446
9. Earnshaw VA, Chaudoir SR. From Conceptualizing to Measuring HIV Stigma: A Review of HIV Stigma Mechanism Measures. AIDS Behav. diciembre de 2009;13(6):1160-77. Disponible en: https://link.springer.com/content/pdf/10.1007/s10461-009-9593-3.pdf DOI: https://doi.org/10.1007/s10461-009-9593-3
10. Mak WWS, Mo PKH, Ma GYK, Lam MYY. Meta-analysis and systematic review of studies on the effectiveness of HIV stigma reduction programs. Soc Sci Med 1982. septiembre de 2017;188:30-40. Disponible en: https://doi.org/10.1016/j.socscimed.2017.06.045 DOI: https://doi.org/10.1016/j.socscimed.2017.06.045
11. National Cancer Institute (NCI). Imaging and Biopsy of HIV-Infected Individuals Undergoing Analytic Treatment Interruption [Internet]. clinicaltrials.gov; mayo 2023 [citado 15 de agosto de 2023]. Report No.: NCT05419024. Disponible en: https://clinicaltrials.gov/study/NCT05419024
12. UNAIDS_FactSheet_es.pdf [Internet]. [citado 14 de agosto de 2023]. Disponible en: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_es.pdf
13. Gobierno de España. Ministerio de Sanidad. Plan Estratégico para la Prevención y Control de la Infección por el VIH y las ITS en España 2021-2030. 2023. https://www.sanidad.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/planNalSida/Plan_de_Prevencion_y_Control1.pdf
14. Noticiero Médico. 1 enero de 2022 [citado 14 de agosto de 2023]. VIH en el Ecuador. Disponible en: https://www.noticieromedico.com/post/vih-en-el-ecuador
15. Ruiz Juan Y, Delgado Matos M, La O Planes M, Rodríguez Labañino ME, Campos Cueva N, Cleger Fonseca M, Correa Fernández M. Prevención en la infección por VIH. Revista Información científica. 2007;54(2). Disponible en: https://revinfcientifica.sld.cu/index.php/ric/article/download/1408/2749
Published
Issue
Section
License
Copyright (c) 2023 Manuel Ezcurdia Barzaga, Henry Jeanpierre Castillo Aveiga, Ana Karen Castillo Aveiga, Nixon Ariel Armijos Quezada (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
